|1.||Ariga, Hiroyoshi: 2 articles (01/2014 - 09/2013)|
|2.||Iguchi-Ariga, Sanae M M: 2 articles (01/2014 - 09/2013)|
|3.||Maita, Hiroshi: 2 articles (01/2014 - 09/2013)|
|4.||Lu, Aiguo: 1 article (12/2015)|
|5.||Lu, Jun: 1 article (12/2015)|
|6.||Guan, Shaopei: 1 article (12/2015)|
|7.||Feng, Bo: 1 article (12/2015)|
|8.||Zheng, Minhua: 1 article (12/2015)|
|9.||Ou, Baochi: 1 article (12/2015)|
|10.||Zhao, Jingkun: 1 article (12/2015)|
|1.||Hepatocellular Carcinoma (Hepatoma)
11/01/2014 - "To explore the effect and molecular mechanism of the unconventional prefoldin RPB5 interactor (URI) in hepatocellular carcinoma HepG2 cells. "
01/01/2013 - "Multiple studies have recently demonstrated the oncogenic property of URI (or RMP, a member of the prefoldin family of molecular chaperones) during progression of hepatocellular carcinoma, ovarian cancer, and possibly prostate cancer. "
12/08/2014 - "In this issue of Cancer Cell, Tummala and colleagues demonstrate that unconventional prefoldin RPB5 interactor (URI) expression in hepatocytes leads to hepatocellular carcinoma (HCC) development by interacting with L-tryptophan/kynurenine/nicotinamide adenine dinucleotide (NAD(+)) metabolism. "
|2.||Prostatic Neoplasms (Prostate Cancer)
|3.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2015 - "Prevalence of the Prefoldin Subunit 5 Gene Deletion in Canine Mammary Tumors."
12/01/2015 - "Prefoldin (PFDN) subunits have been reported upregulated in various tumor types, while the expression and functions of PFDN1 (PFDN subunit 1) in colorectal cancer (CRC) are not well elucidated. "
01/01/2013 - "The amplification and overexpression of Prefoldin (PFND2), a selected candidate mapping to 1q23.3-q24.1, correlated to increasing stage and tumor grade by means of custom-designed and optimized FISH (p = 0.013 and p = 0.023, respectively), and immunohistochemistry (p ≤0.0005 and p = 0.011, respectively), in an independent set of bladder tumors included in tissue arrays. "
06/01/2001 - "This integration of comprehensive sequence annotation, quantitative expression analysis, and tumor amplicon boundaries provide evidence for an additional driver gene prefoldin 4 (PFDN4), coregulated genes, conserved noncoding regions, and associate repetitive elements with regions of genomic instability at this locus."
01/01/2014 - "Unconventional prefoldin RPB5 interactor (URI), which acts as an oncoprotein in solid tumors, is associated with RNA polymerase II subunit 5. However, its impact on multiple myeloma (MM) has not been determined. "
01/01/2008 - "solfataricus, prefoldin expression and apparent molecular weight were not affected by either heat or cold shock."
11/01/2007 - "Levels of protein synthetic machinery components transcriptional activator protein PUR(α,β), elongation factor 2, heterogeneous nuclear ribonucleoprotein K, chaperones 78 kDa glucose-regulated protein, heat shock cognate 71 kDa protein, Hsp 105, stress-70 protein, peptidyl-prolyl cis-trans isomerase A, prefoldin subunit 2, T-complex protein 1 subunit alpha and subunit delta, and degradation principle proteasome subunit alpha type 1 and ubiquitin carboxyl-terminal hydrolase isozyme L1, were different between sex and phase of the EC. "
02/10/2010 - "Sequence analysis was based on BLAST, Panther, KOG and domain (CDD) analyses to assign functional groups for proteins including: cuticle proteins, enzymes (ATPases), ligand binding (histamine binding), molecular chaperone (prefoldin), nucleic acid binding (ribosomal proteins), putative salivary proteins, serine proteases, stress response (heat shock, glycine rich) and transporters. "
|1.||Molecular Chaperones (Chaperone, Molecular)
|2.||Serine Proteases (Serine Protease)
|3.||Chaperonin Containing TCP-1
|4.||Proteasome Endopeptidase Complex (Proteasome)
|5.||Heterogeneous-Nuclear Ribonucleoprotein K
|8.||Peptide Elongation Factor 2 (EF-2)